Summary
Dragon Pharma Sustanon 350, an injectable testosterone blend manufactured under batch number DPSUST-1705 (expiration date May 2020), was submitted by AnabolicLab.com for independent testing. The analysis was conducted by SIMEC AG, a highly regarded pharmaceutical testing laboratory, to verify its composition, label claims, and microbiological safety.
The test results confirmed that the labeled testosterone esters—Testosterone Enanthate, Testosterone Cypionate, and Testosterone Propionate—were present in concentrations close to their specifications. Microbiological testing confirmed no detectable contamination, ensuring the product’s sterility and basic safety. However, slight deviations in measured concentrations from the label claims were noted, highlighting the need for consistent manufacturing practices.
Detailed Report
Product Overview
- Manufacturer: Dragon Pharma
- Product Name: Sustanon 350
- Batch Number: DPSUST-1705
- Expiration Date: May 2020
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: C 81003
- Testing Ordered: 25 February 2019
- Sample Received: 25 February 2019
- Analysis Conducted By: SIMEC AG
- Product Submitted By: AnabolicLab.com
- Analysis Paid For By: AnabolicLab.com
Testing Results
| Testosterone Ester | Specification (Label Claim) | Measured Concentration | Accuracy | Variance |
|---|---|---|---|---|
| Testosterone Enanthate | 200 mg/ml | 185 mg/ml | 92.5% | -7.5% |
| Testosterone Cypionate | 100 mg/ml | 101 mg/ml | 101.0% | +1.0% |
| Testosterone Propionate | 50 mg/ml | 52 mg/ml | 104.0% | +4.0% |
| Microbiological Testing | Result | Specification |
|---|---|---|
| TAMC | Not Detectable/ml | Complies |
| TYMC | Not Detectable/ml | Complies |
Evaluation of Independent Testing
The independent analysis of Dragon Pharma Sustanon 350 revealed acceptable compliance with its label claims for the listed testosterone esters. The concentrations of Testosterone Enanthate, Testosterone Cypionate, and Testosterone Propionate were within reasonable variances, indicating consistent manufacturing practices. Additionally, the absence of microbiological contamination confirmed the product’s sterility and safety for use.
Although the slight underdosage of Testosterone Enanthate (185 mg/ml versus the labeled 200 mg/ml) is worth noting, the overall accuracy of the formulation suggests satisfactory quality control. These findings highlight the importance of independent testing to ensure product integrity and consumer safety.
Conclusion
The analysis of Dragon Pharma Sustanon 350 confirmed its authenticity and compliance with most of its label claims. The product demonstrated good manufacturing consistency and met sterility standards, ensuring its safety for users. Slight deviations in concentration emphasize the need for ongoing quality assurance, underscoring the value of third-party validation in promoting transparency and harm reduction.
Disclaimer
This report is published for educational and harm reduction purposes. Independent testing provides valuable insights; however, these findings pertain solely to the analyzed batch and may not represent the entire product line. Consumers are encouraged to critically assess this information alongside additional independent analyses to make informed decisions.
Discuss the Dragon Pharma Sustanon 350 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)
